Cargando…

Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry

OBJECTIVE: This study aimed to assess the prevalence of pain in patients with RA in clinical remission and analyze the demographic and clinical characteristics of those who experienced persistent pain despite remission status. METHODS: Data from 1,891 patients with RA registered on the Korean Colleg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyoun-Ah, Park, So Young, Shin, Kichul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Rheumatology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351409/ https://www.ncbi.nlm.nih.gov/pubmed/37476424 http://dx.doi.org/10.4078/jrd.22.0005

Ejemplares similares

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
por: Jung, Ju-Yang, et al.
Publicado: (2023)

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry
por: Kim, Jinhyun, et al.
Publicado: (2023)

KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities
por: Kim, Jinhyun, et al.
Publicado: (2021)

Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry
por: Koh, Jung Hee, et al.
Publicado: (2022)

Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry
por: Kim, Seong-Kyu, et al.
Publicado: (2020)

Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry
por: Jung, Seung Min, et al.
Publicado: (2018)

Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2019)

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
por: Lee, Yvonne C, et al.
Publicado: (2011)

Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2021)

A Challenging Target: Persistent Pain During the Remission State in Rheumatoid Arthritis Patients
por: Lim, Doo-Ho
Publicado: (2023)

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission
por: Hammer, Hilde Berner, et al.
Publicado: (2021)

Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
por: Kim, Min Jung, et al.
Publicado: (2022)

Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'
por: Yoshida, Kazuki, et al.
Publicado: (2011)

Introduction: ‘Why is there persistent disease despite aggressive therapy of rheumatoid arthritis?’
por: Miossec, Pierre
Publicado: (2014)

Remission in Rheumatoid Arthritis
por: Shammas, Rania M., et al.
Publicado: (2010)

Ultrasound-defined remission for good functional status in rheumatoid arthritis
por: Ozer, Pinar Kaplan, et al.
Publicado: (2017)

The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
por: Park, Jun Won, et al.
Publicado: (2022)

Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission
por: Vogel, Frederick, et al.
Publicado: (2020)

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
por: Vermeer, Marloes, et al.
Publicado: (2013)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Lee, Sook Yan, et al.
Publicado: (2021)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
por: Koo, Bon San, et al.
Publicado: (2021)

Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability – Saudi Rheumatoid Arthritis Registry
por: Almoallim, Hani, et al.
Publicado: (2019)

Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
por: Ben Abdelghani, Kawther, et al.
Publicado: (2022)

Clinical remission of feline sino-nasal aspergillosis despite evidence of persistent infection
por: Fawsitt, Jack, et al.
Publicado: (2023)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models
por: Kim, Woorim, et al.
Publicado: (2021)

Predicting Imaging Remission in Rheumatoid Arthritis: a Case-control Ultrasound Study
por: Chung, Sang Wan, et al.
Publicado: (2020)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Defining and characterizing sustained remission in patients with rheumatoid arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2017)

Molecular remission at T cell level in patients with rheumatoid arthritis
por: Inamo, Jun, et al.
Publicado: (2021)

Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?
por: Sungur, Can M.
Publicado: (2021)

Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
por: Hèctor, Corominas, et al.
Publicado: (2020)

Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
por: Genitsaridi, Irini, et al.
Publicado: (2020)

Severe Mononeuritis Multiplex due to Rheumatoid Vasculitis in Rheumatoid Arthritis in Sustained Clinical Remission for Decades
por: Tanemoto, Masanobu, et al.
Publicado: (2019)

Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score–Matched Analysis from the Korean College of Rheumatology Biologics Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2020)

Regulatory and other rheumatoid factors in rheumatoid arthritis patients with active disease or in remission
por: Beduleva, Liubov, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g5ecjb6jpg90ejdbn9dgg6tmcu